For example, the curcumin analogs FLLL31 and FLLL32 demonstrate a potent ability to inhibit STAT3 phosphorylation and thus suppress tumor growth in breast cancer by interfering with the DNA-binding domain of STAT3 and initiating apoptosis [174]. This evidence concerns the gene STAT3 and breast carcinoma.